Stocks

Byadmin

May 26, 2020


Investing.com - Financial Markets Worldwide

No results matched your search

Stock Markets5 hours ago (May 26, 2020 09:14AM ET)

© Reuters.

By Geoffrey Smith 

Investing.com — Stocks in focus in premarket trade on Tuesday, May 26th. The broader market is set to open sharply higher amid hopes for a quick economic rebound as the coronavirus recedes in the northern hemisphere.

  • Novavax (NASDAQ:) stock rose 13.3% to $52.25 after the company said it had begun clinical testing on humans for its experimental anti-coronavirus vaccine. It’s now tripled in the last three weeks.
  • Hopes for Novavax’s drug rest largely on the fact that it is a “subunit” vaccine, a more tried and trusted form of drug than the mRNA vaccines under developed by Moderna (NASDAQ:) and Pfizer (NYSE:) partner BioNTech (NASDAQ:).
  • Merck (NYSE:) stock rose 3.7% after it announced two initiatives to catch up in the race to develop a vaccine against the Covid-19 virus.
  • The company is buying Austrian-based Themis Bioscience, and will also work together with the IAVI research institute, whose experimental vaccine uses the same technology that is the basis for Merck’s Ebola virus vaccine.
  • Fiat Chrysler Automobiles (NYSE:) stock rose 7.6% after the company made progress over the weekend on getting state support from Italy.
  • Intesa Sanpaolo (OTC:), Italy’s largest domestic bank, is expected to approve a 6.9 billion euro ($7.6 billion) state-backed loan at a board meeting Tuesday that will be channeled largely to FCA’s suppliers in Italy. Direct support from the government proved politically impossible for FCA due to its extensive non-Italian operations and its tax-efficient Dutch holding company structure.
  • Delta Air Lines (NYSE:) stock rose 7.0% as investors rotated back into cyclical stocks, despite the fact that its Latin American partner airline LATAM (NYSE:) filed for bankruptcy protection over the weekend.
  • Delta had bought a 20% stake in LATAM, the largest carrier in the region, for $1.9 billion last year. LATAM ADRs fell 41% in premarket.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *